183 related articles for article (PubMed ID: 2848172)
1. Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease.
Fleming JO; Trousdale MD; Bradbury J; Stohlman SA; Weiner LP
Microb Pathog; 1987 Jul; 3(1):9-20. PubMed ID: 2848172
[TBL] [Abstract][Full Text] [Related]
2. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies.
Fleming JO; Trousdale MD; el-Zaatari FA; Stohlman SA; Weiner LP
J Virol; 1986 Jun; 58(3):869-75. PubMed ID: 3701929
[TBL] [Abstract][Full Text] [Related]
3. Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity.
Wang FI; Fleming JO; Lai MM
Virology; 1992 Feb; 186(2):742-9. PubMed ID: 1310195
[TBL] [Abstract][Full Text] [Related]
4. The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis.
Wege H; Winter J; Meyermann R
J Gen Virol; 1988 Jan; 69 ( Pt 1)():87-98. PubMed ID: 2447229
[TBL] [Abstract][Full Text] [Related]
5. Interaction of immune and central nervous systems: contribution of anti-viral Thy-1+ cells to demyelination induced by coronavirus JHM.
Fleming JO; Wang FI; Trousdale MD; Hinton DR; Stohlman SA
Reg Immunol; 1993; 5(1):37-43. PubMed ID: 8102242
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus infects and causes demyelination in primate central nervous system.
Murray RS; Cai GY; Hoel K; Zhang JY; Soike KF; Cabirac GF
Virology; 1992 May; 188(1):274-84. PubMed ID: 1314455
[TBL] [Abstract][Full Text] [Related]
7. Early and late CNS-effects of corona virus infection in rats.
Nagashima K; Wege H; ter Meulen V
Adv Exp Med Biol; 1978; 100():395-409. PubMed ID: 211826
[TBL] [Abstract][Full Text] [Related]
8. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody.
Perlman S; Schelper R; Bolger E; Ries D
Microb Pathog; 1987 Mar; 2(3):185-94. PubMed ID: 2853274
[TBL] [Abstract][Full Text] [Related]
9. Beta-endorphin protects mice from neurological disease induced by the murine coronavirus MHV-JHM.
Gilmore W; Moradzadeh DS
J Neuroimmunol; 1993 Oct; 48(1):81-90. PubMed ID: 8227310
[TBL] [Abstract][Full Text] [Related]
10. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence.
Dalziel RG; Lampert PW; Talbot PJ; Buchmeier MJ
J Virol; 1986 Aug; 59(2):463-71. PubMed ID: 3016306
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus JHM induced demyelinating disease: specific domains on the E2-protein are associated with neurovirulence.
Wege H; Winter J; Massa P; Dörries R; ter Meulen V
Adv Exp Med Biol; 1987; 218():307-20. PubMed ID: 2449042
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis.
Fleming JO; Shubin RA; Sussman MA; Casteel N; Stohlman SA
Virology; 1989 Jan; 168(1):162-7. PubMed ID: 2535900
[TBL] [Abstract][Full Text] [Related]
13. Neurovirulence of murine coronavirus JHM temperature-sensitive mutants in rats.
Wege H; Koga M; Watanabe R; Nagashima K; ter Meulen V
Infect Immun; 1983 Mar; 39(3):1316-24. PubMed ID: 6301992
[TBL] [Abstract][Full Text] [Related]
14. Analysis of JHM central nervous system infections in rats.
Parham D; Tereba A; Talbot PJ; Jackson DP; Morris VL
Arch Neurol; 1986 Jul; 43(7):702-8. PubMed ID: 3015091
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.
Sorensen O; Coulter-Mackie MB; Puchalski S; Dales S
Virology; 1984 Sep; 137(2):347-57. PubMed ID: 6091333
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus induced primary demyelination: indications for the involvement of a humoral immune response.
Zimprich F; Winter J; Wege H; Lassmann H
Neuropathol Appl Neurobiol; 1991 Dec; 17(6):469-84. PubMed ID: 1666174
[TBL] [Abstract][Full Text] [Related]
17. Neurovirulence of six different murine coronavirus JHMV variants for rats.
Matsubara Y; Watanabe R; Taguchi F
Virus Res; 1991 Jun; 20(1):45-58. PubMed ID: 1656623
[TBL] [Abstract][Full Text] [Related]
18. Demyelination induced by murine coronavirus JHM infection of congenitally immunodeficient mice.
Houtman JJ; Hinze HC; Fleming JO
Adv Exp Med Biol; 1995; 380():159-63. PubMed ID: 8830473
[TBL] [Abstract][Full Text] [Related]
19. Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease.
Morris VL; Tieszer C; Mackinnon J; Percy D
Virology; 1989 Mar; 169(1):127-36. PubMed ID: 2538027
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.
Sorensen O; Dugre R; Percy D; Dales S
Infect Immun; 1982 Sep; 37(3):1248-60. PubMed ID: 6290393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
